These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 851565)

  • 1. Mammary carcinogenesis in (C3H X RIII) F1 mice under different experimental conditions.
    Guggiari M; Rudali G
    Biomedicine; 1977 Jan; 27(1):27-31. PubMed ID: 851565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary carcinogenesis in (C3H x RIII)F1 mice which receive the trans isomer of a brominated triphenylethylene.
    Rudali G; Vives C; Guggiari M; Montes-Rendon A
    Biomedicine; 1980; 33(4):126-8. PubMed ID: 7426677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary gland development after hypophysial isografts in intact mice of high and low mammary cancer strains.
    Bardin CW; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1966 Feb; 36(2):259-75. PubMed ID: 5948624
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-effect studies on estrogen induced mammary cancers in mice.
    Rudali G; Julien P; Vives C; Apiou F
    Biomedicine; 1978 Apr; 29(2):45-6. PubMed ID: 566588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pregnancy, lactation, and pituitary isografts on the genesis of spontaneous mammary gland tumors in the mouse.
    Bruni JE; Montemurro DG
    Cancer Res; 1971 Dec; 31(12):1903-7. PubMed ID: 5120288
    [No Abstract]   [Full Text] [Related]  

  • 6. Oestrogen and progesterone receptors in mammary tumours of male SHN mice grafted with pituitaries in comparison with females.
    Nagasawa H; Yamamoto K; Furuichi R; Sakamoto S
    Anticancer Res; 1994; 14(1A):61-5. PubMed ID: 8166457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts.
    van der Gugten AA; Röpcke G; van Nie R; Hilgers J
    Cancer Res; 1985 Aug; 45(8):3448-53. PubMed ID: 4016729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
    Edery M; Drosdowsky MA
    Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists.
    Skarda J; Köhlerová E
    J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):145-53. PubMed ID: 16533331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ovariectomy at different ages on development of mammary tumors in (C3H x R3)F1 mice.
    Richardson FL
    J Natl Cancer Inst; 1967 Aug; 39(2):347-54. PubMed ID: 18623949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1971 Jun; 46(6):1251-5. PubMed ID: 5088047
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene.
    Drosdowsky M; Edery M; Guggiari M; Montes-Rendon A; Rudali G; Vives C
    Cancer Res; 1980 May; 40(5):1674-9. PubMed ID: 6245799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1976 May; 56(5):1055-6. PubMed ID: 1036504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and morphological characteristics of mammary tumors in GR mice.
    van Nie R; Dux A
    J Natl Cancer Inst; 1971 Apr; 46(4):885-97. PubMed ID: 5573773
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 18. The incidence of cancer in quantitatively transplanted mammary glands and its relation to age and milk agent of the donor and host mice.
    Hoshino K; Gardner WU; Pawlikowski RA
    Cancer Res; 1965 Nov; 25(10):1792-803. PubMed ID: 4285689
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
    Girardi AJ; Dion AS; Pomenti AA; Holben JA
    J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.